DR-309 Unraveling the mystery of early-onset colorectal cancer
The incidence of early-onset colorectal cancer (eoCRC) in patients < 50 years of age is rapidly increasing. Despite indications that the tumor biology is different and more aggressive than older-onset (oo) CRC, age-specific treatments are lacking. To optimally treat these patients, eoCRC specific tumor biology needs to be better understood. We aim to explore biological differences, differences in treatment response between eoCRC and propensity score matched ooCRC and generate novel co-culture laboratory models of organoids AND CAFs to study eoCRC biology.
Tineke Buffart, VU Medical Center, Amsterdam UMC, the Netherlands
Terug naar nieuwsMeer nieuws
Tussenstand GENAYA-project
In april 2022 is Hartwig Medical Foundation gestart met het GENAYA-project. Wat is de stand van zaken? Wat houdt GENAYA …
Measuring the effects of radiotherapy on cancer may open up avenues for treatment
Radiotherapy works by damaging the DNA of cancer cells. It’s an effective strategy overall, but many cancers have subsets of …
Meerwaarde Whole Genome Sequencing duidelijk voor Antoni van Leeuwenhoek
Het Antoni van Leeuwenhoek in Amsterdam maakt al enkele jaren structureel gebruik van Whole Genome Sequencing (WGS), in samenwerking met …
Bij zeldzame kankers is het belangrijk om het DNA te ontrafelen. 21% van de mensen met kanker heeft een zeldzame vorm.